Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
17.18
-0.22 (-1.26%)
Dec 20, 2024, 4:00 PM EST - Market closed
Travere Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$23.46
Upside
+36.55%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Hold Maintains $12 → $22 | Hold | Maintains | $12 → $22 | +28.06% | Nov 14, 2024 |
Scotiabank | Scotiabank | Buy Maintains $23 → $27 | Buy | Maintains | $23 → $27 | +57.16% | Nov 1, 2024 |
Barclays | Barclays | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | +16.41% | Nov 1, 2024 |
Wells Fargo | Wells Fargo | Hold → Buy Upgrades $9 → $27 | Hold → Buy | Upgrades | $9 → $27 | +57.16% | Oct 21, 2024 |
Scotiabank | Scotiabank | Buy Initiates $23 | Buy | Initiates | $23 | +33.88% | Oct 16, 2024 |
Leerink Partners | Leerink Partners | Buy Maintains $20 → $40 | Buy | Maintains | $20 → $40 | +132.83% | Oct 11, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +16.41% | Oct 9, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $23 → $41 | Strong Buy | Maintains | $23 → $41 | +138.65% | Oct 9, 2024 |
Wedbush | Wedbush | Buy Maintains $17 → $25 | Buy | Maintains | $17 → $25 | +45.52% | Oct 9, 2024 |
Leerink Partners | Leerink Partners | Buy Reiterates $20 | Buy | Reiterates | $20 | +16.41% | Oct 8, 2024 |
Barclays | Barclays | Buy Maintains $14 → $18 | Buy | Maintains | $14 → $18 | +4.77% | Oct 1, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $23 → $22 | Strong Buy | Maintains | $23 → $22 | +28.06% | Sep 30, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $23 → $19 | Strong Buy | Maintains | $23 → $19 | +10.59% | Sep 27, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $25 → $23 | Strong Buy | Maintains | $25 → $23 | +33.88% | Sep 27, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +4.77% | Sep 27, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 → $18 | Strong Buy | Maintains | $23 → $18 | +4.77% | Sep 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.